Zusammenfassung
Die Frage der Kausalität eines offenen Foramen ovale bei ischämischem Schlaganfall sowie der optimalen Sekundärprävention dieser Patienten wird derzeit kontrovers diskutiert. Die beste verfügbare Evidenz stammt aus Fall-Kontroll-Studien, die in ihrer Gesamtheit auf einen Zusammenhang hindeuten, diesen aber letztlich nicht beweisen können. Neben paradoxen Embolien sind andere Pathomechanismen denkbar, deren genauer Nachweis in der Praxis jedoch nur selten gelingt. Bei niedrigem Rezidivrisiko zumindest für jüngere Patienten kann bei der momentanen Studienlage keine evidenzbasierte Empfehlung zur Sekundärprävention gegeben werden. Mehrere derzeit laufende randomisierte Studien sollen hier in einigen Jahren Klärung bringen. Primäres und sekundäres Risiko erscheinen jedoch deutlich erhöht bei begleitendem Vorhofseptumaneurysma. Zur weiteren Risikostratifizierung sollte der Einfluss begleitender Faktoren wie Shuntgröße und Gerinnungsstörungen weiter untersucht werden.
Summary
The role of a patent foramen ovale (PFO) in stroke is still regarded as controversial, as is the optimal strategy of secondary prevention for such patients. The best available evidence is derived from case-control studies, which in all show a statistically significant relationship but cannot be judged as conclusive for methodologic reasons. Besides paradoxic embolism, different pathomechanisms of stroke due to abnormalities of the atrial septum are possible that can rarely be verified in clinical routine. While the risk of stroke recurrence seems to be low at least for younger patients, to date no definite recommendations for secondary prevention can be given. Several ongoing randomized clinical trials might increase the store of evidence in this topic over the next years. However, primary and secondary risk seem to be substantially increased for the combined defect of PFO and atrial septum aneurysm. To allow further risk stratification, other potentially important factors such as shunt size and coagulation disorders should be targeted in future studies.
Literatur
Jauss M, Zanette E (2000) Detection of right-to-left shunt with ultrasound contrast agent and transcranial Doppler sonography. Cerebrovasc Dis 10:490–496
Hanley PC, Tajik AJ, Hynes JK et al.(1985) Diagnosis and classification of atrial septal aneurysm by two-dimensional echocardiography: report of 80 consecutive cases. J Am Coll Cardiol 6:1370–1382
Overell JR, Bone I, Lees KR (2000) Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies. Neurology 55:1172–1179
Lamy C, Giannesini C, Zuber M et al. (2002) Clinical and imaging findings in cryptogenic stroke patients with and without patent foramen ovale: the PFO-VSA Study. Atrial Septal Aneurysm. Stroke 33:706–711
Homma S, Sacco RL, Di Tullio MR et al. (2002) Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study. Circulation 105:2625–2631
Agmon Y, Khandheria BK, Meissner I et al. (2001) Comparison of frequency of patent foramen ovale by transesophageal echocardiography in patients with cerebral ischemic events versus in subjects in the general population. Am J Cardiol 88:330–332
Lethen H, Flachskampf FA, Schneider R et al. (1997) Frequency of deep vein thrombosis in patients with patent foramen ovale and ischemic stroke or transient ischemic attack. Am J Cardiol 80:1066–1069
Ranoux D, Cohen A, Cabanes L et al. (1993) Patent foramen ovale: is stroke due to paradoxical embolism? Stroke 24:31–34
Cramer SC, Rordorf G, Maki JH et al. (2004) Increased pelvic vein thrombi in cryptogenic stroke: results of the Paradoxical Emboli from Large Veins in Ischemic Stroke (PELVIS) study. Stroke 35:46–50
Schneider B, Hanrath P, Vogel P et al. (1990) Improved morphologic characterization of atrial septal aneurysm by transesophageal echocardiography: relation to cerebrovascular events. J Am Coll Cardiol 16:1000–1009
Mugge A, Daniel WG, Angermann C et al. (1995) Atrial septal aneurysm in adult patients. A multicenter study using transthoracic and transesophageal echocardiography. Circulation 91:2785–2792
Berthet K, Lavergne T, Cohen A et al. (2000) Significant association of atrial vulnerability with atrial septal abnormalities in young patients with ischemic stroke of unknown cause. Stroke 31(2):398–403
Schneider B, Hofmann T, Meinertz T (1999) Is there an association of atrial septal aneurysm with arrhythmias? Cardiology 91:87–91
Hagen PT, Scholz DG, Edwards WD (1984) Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc 59:17–20
Meissner I, Whisnant JP, Khandheria BK et al. (1999) Prevalence of potential risk factors for stroke assessed by transesophageal echocardiography and carotid ultrasonography: the SPARC study. Stroke Prevention: Assessment of Risk in a Community. Mayo Clin Proc 74:862–869
Kolominsky-Rabas PL, Weber M, Gefeller O et al. (2001) Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes: a population-based study. Stroke 32:2735–2740
Psaty BM, Koepsell TD, Manolio TA et al. (1990) Risk ratios and risk differences in estimating the effect of risk factors for cardiovascular disease in the elderly. J Clin Epidemiol 43:961–970
Steiner MM, Di Tullio MR, Rundek T et al. (1998) Patent foramen ovale size and embolic brain imaging findings among patients with ischemic stroke. Stroke 29:944–948
Serena J, Segura T, Perez-Ayuso MJ et al. (1998) The need to quantify right-to-left shunt in acute ischemic stroke: a case-control study. Stroke 29:1322–1328
Homma S, Di Tullio MR, Sacco RL et al. (1994) Characteristics of patent foramen ovale associated with cryptogenic stroke. A biplane transesophageal echocardiographic study. Stroke 25:582–586
Stone DA, Godard J, Corretti MC et al. (1996) Patent foramen ovale: association between the degree of shunt by contrast transesophageal echocardiography and the risk of future ischemic neurologic events. Am Heart J 131:158–161
Nabavi DG, Junker R, Wolff E et al. (1998) Prevalence of factor V Leiden mutation in young adults with cerebral ischaemia: a case-control study on 225 patients. J Neurol 245:653–658
Comess KA, DeRook FA, Beach KW et al. (1994) Transesophageal echocardiography and carotid ultrasound in patients with cerebral ischemia: prevalence of findings and recurrent stroke risk. J Am Coll Cardiol 23:1598–1603
Mas JL, Arquizan C, Lamy C et al. (2001) Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 345:1740–1746
Bogousslavsky J, Garazi S, Jeanrenaud X et al. (1996) Stroke recurrence in patients with patent foramen ovale: the Lausanne Study. Lausanne Stroke with Paradoxal Embolism Study Group. Neurology 46:1301–1305
Nedeltchev K, Arnold M, Wahl A et al. (2002) Outcome of patients with cryptogenic stroke and patent foramen ovale. J Neurol Neurosurg Psychiatry 72:347–350
Mas JL, Zuber M (1995) Recurrent cerebrovascular events in patients with patent foramen ovale, atrial septal aneurysm, or both and cryptogenic stroke or transient ischemic attack. French Study Group on Patent Foramen Ovale and Atrial Septal Aneurysm. Am Heart J 130:1083–1088
Kraywinkel K, Göstler M, Haass AH, Diener HC, Weimar C (2005) Diagnostischer Gewinn der transösophagealen Echokardiographie nach TIA und ischämischem Schlaganfall. Akt Neuro (in press)
Jauss M (2004) Die Paradoxe Hirnembolie—Diagnosestellung und Langzeitverlauf. http://www.geb.uni-giessen.de/geb/volltexte/2004/1636/. URN: urn:nbn:de:hebis:26-opus-16363. Habilitationsschrift, Universität Giessen (Stand 11.10.2004)
Khairy P, O’Donnell CP, Landzberg MJ (2003) Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli: a systematic review. Ann Intern Med 139:753–760
De Castro S, Cartoni D, Fiorelli M et al. (2000) Morphological and functional characteristics of patent foramen ovale and their embolic implications. Stroke 31:2407–2413
Messe SR, Silverman IE, Kizer JR et al. (2004) Practice parameter: recurrent stroke with patent foramen ovale and atrial septal aneurysm: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 62:1042–1050
Petty GW, Brown RD Jr, Whisnant JP et al. (2000) Ischemic stroke subtypes: a population-based study of functional outcome, survival, and recurrence. Stroke 31:1062–1068
Sacco RL, Shi T, Zamanillo MC et al. (1994) Predictors of mortality and recurrence after hospitalized cerebral infarction in an urban community: the Northern Manhattan Stroke Study. Neurology 44:626–634
Leys D, Kwiecinski H, Bogousslavsky J et al. (2004) Prevention. European Stroke Initiative. Cerebrovasc Dis 17(Suppl 2):15–29
Deutsche Gesellschaft für Neurologie (2003) Leitlinie „Primäre und sekundäre Prävention der zerebralen Ischämie“. 25.3.2003. http://www.dgn.org/127.0.html. (Stand 11.10.2004)
German Stroke Study Collaboration (2004) Predicting outcome after acute ischemic stroke: an external validation of prognostic models. Neurology 62:581–585
Ehrenfeld CE, Kraywinkel K, Weimar C et al. (2003) Langzeitverlauf zerebrovaskulärer Erkrankungen unterschiedlicher Ätiologie. Aktuelle Neurol V132:Abstract
Danksagung
Der Studienverbund Schlaganfall wurde von 2000–2002 im Rahmen des Kompetenznetzes Schlaganfall vom Bundesministerium für Bildung und Forschung gefördert. Seit 2003 erfolgt eine Förderung durch die Deutsche Forschungsgemeinschaft (DI 327/8-1).
Interessenkonflikt
Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kraywinkel, K., Jauss, M., Diener, HC. et al. Offenes Foramen ovale, Vorhofseptumaneurysma und Hirninfarkt. Nervenarzt 76, 935–942 (2005). https://doi.org/10.1007/s00115-004-1874-5
Issue Date:
DOI: https://doi.org/10.1007/s00115-004-1874-5